An Overview of Primary Pulmonary Hypertension
Primary Pulmonary Hypertension, or PPH, is a very rare disease that is only diagnosed when an individual has hypertension with no known cause.
It has been linked to both fen-phen and Avandia in recent years but has existed for much longer than either of those drugs.
PPH is a disease that results in fewer than 500 new diagnoses each year.
Because of this, it is very hard to study the disease and how it develops.
Despite this, it is a cause of death in more than 3,000 people per year and 160,000 hospital discharges in 2000 were related to PPH.
This suggests that many people who have PPH have not had it diagnosed.
The disease affects all groups of people equally but has a slightly higher rate of occurrence in women between the ages of 20 and 40.
This is a more recent development that could be linked to women mainly taking the diet drug fen-phen.
The symptoms of PPH include shortness of breath, particularly following exercise; chronic and/or excessive fatigue; dizziness, weakness, or periodic fainting; chest pains; and lips and skin that turn somewhat blue.
The last symptom is an indicator that the disease is no longer in its early stages.
PPH is a progressive disease which means that it gets worse as time progresses.
That is one of the reasons that early diagnosis is important.
The problem with these symptoms is that, in many cases, they are indicative of a variety of ailments and diseases.
They are rather vague until a person's lips and skin start turning blue.
These symptoms are also common in individuals who are overweight or out of shape which makes diagnosing the disease even more difficult.
Primary Pulmonary Hypertension is a disease that constricts the flow of blood from the heart to the lungs.
It does this because the pulmonary artery becomes progressively narrower with time which makes it harder for the heart to pump blood to the lungs.
With time, this can lead to failure of the right side of the heart.
The "primary" of PPH comes from not knowing what its actual cause is.
This can be said even though fen-phen and Avandia have been tied to the disease.
Although they are tied to the disease, no one is quite sure how they relate to PPH so it is still Primary Pulmonary Hypertension.
If you would like more information concerning Primary Pulmonary Hypertension, fen-phen, Avandia, and their links, contact the PPH attorneys of Williams Kherkher at 1-866-950-9000 or via their website, http://www.
pphlawsuitattorney.
com.
Their team will be more than happy to answer any questions you might have concerning PPH, Avandia, or Fen-Phen.
It has been linked to both fen-phen and Avandia in recent years but has existed for much longer than either of those drugs.
PPH is a disease that results in fewer than 500 new diagnoses each year.
Because of this, it is very hard to study the disease and how it develops.
Despite this, it is a cause of death in more than 3,000 people per year and 160,000 hospital discharges in 2000 were related to PPH.
This suggests that many people who have PPH have not had it diagnosed.
The disease affects all groups of people equally but has a slightly higher rate of occurrence in women between the ages of 20 and 40.
This is a more recent development that could be linked to women mainly taking the diet drug fen-phen.
The symptoms of PPH include shortness of breath, particularly following exercise; chronic and/or excessive fatigue; dizziness, weakness, or periodic fainting; chest pains; and lips and skin that turn somewhat blue.
The last symptom is an indicator that the disease is no longer in its early stages.
PPH is a progressive disease which means that it gets worse as time progresses.
That is one of the reasons that early diagnosis is important.
The problem with these symptoms is that, in many cases, they are indicative of a variety of ailments and diseases.
They are rather vague until a person's lips and skin start turning blue.
These symptoms are also common in individuals who are overweight or out of shape which makes diagnosing the disease even more difficult.
Primary Pulmonary Hypertension is a disease that constricts the flow of blood from the heart to the lungs.
It does this because the pulmonary artery becomes progressively narrower with time which makes it harder for the heart to pump blood to the lungs.
With time, this can lead to failure of the right side of the heart.
The "primary" of PPH comes from not knowing what its actual cause is.
This can be said even though fen-phen and Avandia have been tied to the disease.
Although they are tied to the disease, no one is quite sure how they relate to PPH so it is still Primary Pulmonary Hypertension.
If you would like more information concerning Primary Pulmonary Hypertension, fen-phen, Avandia, and their links, contact the PPH attorneys of Williams Kherkher at 1-866-950-9000 or via their website, http://www.
pphlawsuitattorney.
com.
Their team will be more than happy to answer any questions you might have concerning PPH, Avandia, or Fen-Phen.